Understanding the T cell immune response in SARS coronavirus infection
Open Access
- 1 July 2012
- journal article
- review article
- Published by Taylor & Francis in Emerging Microbes & Infections
- Vol. 1 (1), 1-6
- https://doi.org/10.1038/emi.2012.26
Abstract
The severe acute respiratory syndrome (SARS) epidemic started in late 2002 and swiftly spread across 5 continents with a mortality rate of around 10%. Although the epidemic was eventually controlle...Keywords
This publication has 77 references indexed in Scilit:
- Chimeric severe acute respiratory syndrome coronavirus (SARS-CoV) S glycoprotein and influenza matrix 1 efficiently form virus-like particles (VLPs) that protect mice against challenge with SARS-CoVVaccine, 2011
- Effect of mucosal and systemic immunization with virus‐like particles of severe acute respiratory syndrome coronavirus in miceImmunology, 2010
- Protective and Pathologic Roles of the Immune Response to Mouse Hepatitis Virus Type 1: Implications for Severe Acute Respiratory SyndromeJournal of Virology, 2009
- Characterization of SARS-CoV-specific memory T cells from recovered individuals 4 years after infectionArchiv für die gesamte Virusforschung, 2009
- Humoral and Cellular Immune Responses Induced by 3a DNA Vaccines against Severe Acute Respiratory Syndrome (SARS) or SARS-Like Coronavirus in MiceClinical and Vaccine Immunology, 2009
- SARS coronavirus accessory proteinsVirus Research, 2007
- Severe Acute Respiratory Syndrome Coronavirus as an Agent of Emerging and Reemerging InfectionClinical Microbiology Reviews, 2007
- Persistent memory CD4+ and CD8+ T-cell responses in recovered severe acute respiratory syndrome (SARS) patients to SARS coronavirus M antigenJournal of General Virology, 2007
- Immunization with vaccinia virus induces polyfunctional and phenotypically distinctive CD8+ T cell responsesThe Journal of Experimental Medicine, 2007
- An efficient method to make human monoclonal antibodies from memory B cells: potent neutralization of SARS coronavirusNature Medicine, 2004